PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)37.50 %Percentage2010/20112010-04-012011-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)39.23 %Percentage2011/20122011-04-012012-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)30.89 %Percentage2012/20132012-04-012013-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)30.90 %Percentage2013/2014_Q12013-04-012013-06-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)34.60 %Percentage2013/20142013-04-012014-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)31.10 %Percentage2013/2014_Q22013-07-012013-09-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)30.50 %Percentage2013/2014_Q32013-10-012013-12-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)34.60 %Percentage2013/2014_Q42014-01-012014-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)40.10 %Percentage2014/20152014-04-012015-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)36.50 %Percentage2014/2015_Q12014-04-012014-06-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)35.60 %Percentage2014/2015_Q22014-07-012014-09-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)38.80 %Percentage2014/2015_Q32014-10-012014-12-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)40.10 %Percentage2014/2015_Q42015-01-012015-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)38.00 %Percentage2015/2016_Q12015-04-012015-06-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)31.10 %Percentage2015/20162015-04-012016-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)34.80 %Percentage2015/2016_Q22015-07-012015-09-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)33.30 %Percentage2015/2016_Q32015-10-012015-12-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)31.10 %Percentage2015/2016_Q42016-01-012016-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)38.08 %Percentage2016/20172016-04-012017-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)32.51 %Percentage2016/2017_Q12016-04-012016-06-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)37.93 %Percentage2016/2017_Q22016-07-012016-09-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)37.89 %Percentage2016/2017_Q32016-10-012016-12-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)38.08 %Percentage2016/2017_Q42017-01-012017-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)32.11 %Percentage2017/20182017-04-012018-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)36.93 %Percentage2017/2018_Q12017-04-012017-06-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)33.91 %Percentage2017/2018_Q22017-07-012017-09-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)29.96 %Percentage2017/2018_Q32017-10-012017-12-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)32.11 %Percentage2017/2018_Q42018-01-012018-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)30.33 %Percentage2018/2019_Q12018-04-012018-06-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)29.20 %Percentage2018/20192018-04-012019-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)26.61 %Percentage2018/2019_Q22018-07-012018-09-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)31.50 %Percentage2018/2019_Q32018-10-012018-12-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)29.20 %Percentage2018/2019_Q42019-01-012019-03-31Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)28.71 %Percentage2019/2020_Q12019-04-012019-06-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)32.49 %Percentage2019/2020_Q22019-07-012019-09-30Quarterly PHOF77% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)31.84 %Percentage2019/2020_Q32019-10-012019-12-31Quarterly